AstraZeneca cuts the ribbon on its $1bn R&D lab in Cambridge

After years of delays and rising costs, AstraZeneca has formally unveiled its $1 billion R&D facility in

AZ, GSK and Cambridge Uni will set up COVID-19 testing centr...

AstraZeneca looks to speed up overdue HQ

Construction of AstraZeneca’s new global and R&D headquarters in Cambridge should have been completed last autumn – but builders are struggling to meet a revised deadline of May 2019.

Bicycle Therapeutics signs cancer development deal with CRUK

Second deal in weeks for innovative peptides-focused biotech

Will the UK ever produce a world-class biotech company?

Kymab, F-star and Mission Therapeutics among crop of new UK biotechs.